Quality of life
Cancer
CANCER
QOL was evaluated using the QLQ-C30 questionnaire; the response rate in Japanese patients was 100% in both groups at baseline and at least 92% in each group at each assessment time through to Week 49. As indicated in Mean changes in EORTC QLQ-C30 scores for Global Health Status according to treatment in all randomized Japanese patients. EORTC, European Organization for Research and Treatment of Cancer; FU1, follow-up 1; FU2, follow-up 2; QLQ-C30, Quality of Life Questionnaire-Core 30.